INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $27,000 | -49.1% | 23,557 | 0.0% | 0.00% | – |
| Q4 2021 | $53,000 | -80.1% | 23,557 | -69.7% | 0.00% | -100.0% |
| Q3 2021 | $266,000 | +14.2% | 77,785 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $233,000 | -76.5% | 77,785 | -74.7% | 0.00% | -75.0% |
| Q1 2021 | $993,000 | +228.8% | 307,533 | +116.0% | 0.01% | +166.7% |
| Q4 2020 | $302,000 | -7.1% | 142,354 | -48.7% | 0.00% | 0.0% |
| Q3 2020 | $325,000 | +29.5% | 277,550 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $251,000 | +13.1% | 277,550 | +4.9% | 0.00% | 0.0% |
| Q1 2020 | $222,000 | +65.7% | 264,549 | +89.7% | 0.00% | +200.0% |
| Q4 2019 | $134,000 | -14.1% | 139,453 | -7.7% | 0.00% | -50.0% |
| Q3 2019 | $156,000 | -57.0% | 151,136 | -25.0% | 0.00% | -60.0% |
| Q2 2019 | $363,000 | +0.6% | 201,438 | +5.0% | 0.01% | 0.0% |
| Q1 2019 | $361,000 | +137.5% | 191,927 | +48.6% | 0.01% | +66.7% |
| Q4 2018 | $152,000 | -49.2% | 129,127 | +17.0% | 0.00% | -25.0% |
| Q3 2018 | $299,000 | -7.1% | 110,354 | -34.6% | 0.00% | -20.0% |
| Q2 2018 | $322,000 | -28.3% | 168,727 | -21.1% | 0.01% | -28.6% |
| Q1 2018 | $449,000 | +1.4% | 213,827 | -2.1% | 0.01% | -12.5% |
| Q4 2017 | $443,000 | +235.6% | 218,427 | +119.5% | 0.01% | +166.7% |
| Q3 2017 | $132,000 | -76.3% | 99,527 | -71.9% | 0.00% | -75.0% |
| Q2 2017 | $556,000 | -56.0% | 353,891 | -9.6% | 0.01% | -53.8% |
| Q1 2017 | $1,265,000 | +271.0% | 391,671 | +55.0% | 0.03% | +271.4% |
| Q4 2016 | $341,000 | +2031.2% | 252,771 | +2033.1% | 0.01% | – |
| Q2 2016 | $16,000 | -74.2% | 11,850 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $62,000 | -33.3% | 11,850 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $93,000 | -49.7% | 11,850 | -46.0% | 0.00% | -50.0% |
| Q3 2015 | $185,000 | -69.9% | 21,950 | -60.8% | 0.00% | -66.7% |
| Q2 2015 | $614,000 | -39.4% | 56,050 | -22.7% | 0.01% | -29.4% |
| Q1 2015 | $1,013,000 | -55.6% | 72,485 | -46.4% | 0.02% | -56.4% |
| Q4 2014 | $2,282,000 | +201.9% | 135,108 | +139.8% | 0.04% | +200.0% |
| Q3 2014 | $756,000 | – | 56,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |